how many units is .5 mg of semaglutide to Use Ozempic® Pen how many units is the

What this 1-day workshop will cover: How to safely dose and monitor your patients weight loss How to recognize non responding patients and what to do next How to support your patients weight loss with GLP1s and supplements 8:00 am Weight Loss Introduction James LaValle, RPh, CCN, MT Metaflammation and understanding Mitochondrial interference Factors in metaflammation 9:00 am Insulin Resistance James LaValle, RPh, CCN, MT Cell signaling Impact of low thyroid Impact of Cortisol and stress Impact of environmental burden - Pesticides - Heavy metals - Biotoxins Key nutrients Peptides GLP-1/GIP agonists 10:30 am Managing Cortisol and Thyroid Hormone Gordon Crozier, DO Working within circadian timing Strategies for thyroid support Key nutrients, Peptides and compounded Rx 11:30 am Sex Hormones and Weight Loss Gordon Crozier, DO Testosterone Estrogens Estradiol/Estriol Progesterone balance Key nutrients 1:30 pm Exercise: Preserving Muscle During Weight Loss Cliff Edberg, RD, CPT 2:00 pm Gut-Immune-Brain Connection James LaValle, RPh, CCN, MT Impact of the Microbiome on hunger signaling and satiety Reward cascade and Hedonic Urge the dopamine connection Correcting for Gut permeability Key nutrients, peptides and compounded Rx 3:30 pm Diet: The Most Effective Diet for Lean Mass Retention and Glucose Regulation Laura LaValle, RDN, LD Impact of food sensitivities and allergies 4:30 pm Putting It All Together James LaValle, RPh, CCN, MT Options for other compounds when GLP-1 are not indicated or tolerated

Lock in pricing plus enjoy free shipping Pause, skip and cancel anytime Never run out Supplement Facts Serving size: 1 Capsule Servings Per Container: Subscribe & Save up to 10% OFF on select products: Save money

You can get Zepbound through traditional insurance routes but Eli Lilly also offers a cash-pay option through their Lilly Direct program

Histological staining revealed the anti-inflammatory effect of piperine especially in the ankle joints (Bang et al

Respir Res (2018) 19(1):56

Verspohl EJ: Novel therapeutics for type 2 diabetes: Incretin hormone mimetics (glucagon-like peptide-1 receptor agonists) and dipeptidyl peptidase-4 inhibitors